Thus, we speculate that the ADT-induced production of CCL2 via TNF signaling is a feature of a population resembling PSA−/lo (progenitor) cells, and contributes to the aggressive tumor phenotype of this cancer population, which expands following ADT [45]. The gene discussed is TNF; the disease is cancer.